Floatz logo

Prothrombin Complex Concentrate, Human

Anticoagulant-induced Bleeding

The George Institute for Global Health, ChinaN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Anticoagulant-induced Bleeding cohort.

Asset / SponsorPhaseRating
Rivaroxaban
Brigham and Women's Hospital
Phase 4BBB
NADROPARIN
Qilu Hospital of Shandong University
Phase 4BB
HEPARIN
First Affiliated Hospital Xi'an Jiaotong University
Phase 1/2CCC
PHYTONADIONE, (E)-(±)-
The George Institute for Global Health, China
N/AD
Edoxaban
Brigham and Women's Hospital
D
Dabigatran
Brigham and Women's Hospital
D
Fresh Frozen Plasma
The George Institute for Global Health, China
N/AD

Same molecule, other indications

Prothrombin Complex Concentrate, Human is also rated in:

Cerebral HemorrhageDormant
B
Indicative ·
61 / 100
View asset →
heart valve disorderDormant
B
Indicative ·
61 / 100
View asset →
Intraventricular HemorrhageDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →